相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
Lei Miao et al.
CANCER RESEARCH (2017)
Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of proinflammatory monocytes
Fabiany da C. Goncalves et al.
SCIENTIFIC REPORTS (2017)
Potentiation of TRAIL killing activity by multimerization through isoleucine zipper hexamerization motif
Ji Hye Han et al.
BMB REPORTS (2016)
Onto better TRAILs for cancer treatment
D. de Miguel et al.
CELL DEATH AND DIFFERENTIATION (2016)
Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma
Seung Ah Choi et al.
STEM CELLS AND DEVELOPMENT (2016)
Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity
J. Yan et al.
CELL DEATH & DISEASE (2016)
Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial
Hanno Niess et al.
BMC CANCER (2015)
Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11
P. Dao et al.
CANCER LETTERS (2015)
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Clifford J. Whatcott et al.
CLINICAL CANCER RESEARCH (2015)
Pancreatic cancer: current understanding of molecular and genetic aetiologies
Tamara M. H. Gall et al.
POSTGRADUATE MEDICAL JOURNAL (2015)
Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle
Mohsen Khorashadizadeh et al.
TUMOR BIOLOGY (2015)
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing
Malvina Prapa et al.
ONCOTARGET (2015)
TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions
Hee-Jun Na et al.
ANGIOGENESIS (2014)
TRAIL Mediated Signaling in Pancreatic Cancer
Daniele Rubert Nogueira et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway
Zhiyu Chen et al.
CANCER LETTERS (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
Mesenchymal stem cells, cancer challenges and new directions
Nedime Serakinci et al.
EUROPEAN JOURNAL OF CANCER (2014)
TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice
Q. Deng et al.
GENE THERAPY (2014)
Surrounding Pancreatic Adenocarcinoma by Killer Mesenchymal Stromal/Stem Cells
Giulia Golinelli et al.
HUMAN GENE THERAPY (2014)
Immunoglobulin Fc Domain Fusion to TRAIL Significantly Prolongs Its Plasma Half-Life and Enhances Its Antitumor Activity
Haizhen Wang et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Influence of the Implantation Site on the Sensitivity of Patient Pancreatic Tumor Xenografts to Apo2L/TRAIL Therapy
Rohit Sharma et al.
PANCREAS (2014)
Therapeutic options for the management of pancreatic cancer
Maria L. Rossi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
Wanchun Shi et al.
BIOSCIENCE TRENDS (2014)
Stem cell-based therapies for cancer treatment: separating hope from hype
Daniel W. Stuckey et al.
NATURE REVIEWS CANCER (2014)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Gene therapy in B-NHL cell line using adenovirus-mediated transfer of secretable trimeric TRAIL gene expression driven by CD20 promoter
Xiang-Fei Yuan et al.
EXPERIMENTAL HEMATOLOGY (2013)
APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors
Christian Gieffers et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery
Eike Gallmeier et al.
PLOS ONE (2013)
TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells
M. R. Moniri et al.
CANCER GENE THERAPY (2012)
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
Mert Erkan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Pancreatic ductal adenocarcinoma screening: New perspectives
Raffaele Pezzilli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes
Liangran Guo et al.
NANOTECHNOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
Giulia Grisendi et al.
CANCER RESEARCH (2010)
TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors
Dominic Stadel et al.
CLINICAL CANCER RESEARCH (2010)
Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment
Shannon Kidd et al.
CYTOTHERAPY (2010)
A Genetically Encoded Multifunctional TRAIL Trimer Facilitates Cell-Specific Targeting and Tumor Cell Killing
Dirk Spitzer et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
H. Schrezenmeier et al.
VOX SANGUINIS (2010)
Stem cells are resistant to TRAIL receptor-mediated apoptosis
Eva Szegezdi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells
Dmitri V. Rozanov et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo
Beatrice Cousin et al.
PLOS ONE (2009)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Laura S. Sasportas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
B. M. Beckermann et al.
BRITISH JOURNAL OF CANCER (2008)
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L
D. Berg et al.
CELL DEATH AND DIFFERENTIATION (2007)
Pancreatic cancer-associated stroma production
Murray Korc
AMERICAN JOURNAL OF SURGERY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Improvement of expression level and bioactivity of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) by a novel zinc ion feeding strategy
Ai-You Sun et al.
BIOTECHNOLOGY LETTERS (2006)
TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells
G. Cantarella et al.
BRITISH JOURNAL OF CANCER (2006)
Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo -: a role in tumour cell survival?
I Holen et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice
BL Hylander et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
The secretable form of trimeric TRAIL, a potent inducer of apoptosis
MH Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy
K Shah et al.
CANCER RESEARCH (2004)
TRAIL and apoptosis induction by TNF-family death receptors
SL Wang et al.
ONCOGENE (2003)
Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells
A Trauzold et al.
BRITISH JOURNAL OF CANCER (2003)
Apo2L/TRAIL and its death and decoy receptors
HN LeBlanc et al.
CELL DEATH AND DIFFERENTIATION (2003)
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
M Jo et al.
NATURE MEDICINE (2000)
分享论文
